Abstract

The synthesis of four α,ω-diaminoalkane-N,N′-diacetic acid and their dinuclear 2,2′-bipyridine palladium(II) and platinum(II) complexes of general formula [M 2(bipy) 2(DADA)] (NO 3) 2 (where M is Pd(II) or Pt(II), bipy is 2,2′-bipyridine, DADA is dianion of 1,4-diaminobutane-N,N′-diacetic acid (DBDA), 1,6-diaminohexane-N,N′-diacetic acid (DHDA), 1,8-diaminooctane-N,N′-diacetic acid (DODA), or 1,10-diaminodecane-N-N′-diacetic acid (DDDA) has been achieved. They have been characterized by elemental analysis, conductivity measurements, electronic absorption, and infrared and variable temperature 1H NMR spectroscopy. The above eight dinuclear palladium(II) and platinum(II) complexes have been tested for cytotoxicity against P388 lymphocytic leukemia cells. Out of them, [Pt 2(bipy) 2(DDDA)(NO 3) 2 and [Pd 2(bipy) 2(DBDA)](NO 3) 2 show lower I.D. 50 values as compared to cisplatin. The binding of [Pt 2(bipy) 2(DODA)](NO 3) 2 and [M 2(bipy) 2(DHDA)](NO 3) 2 with calf thymus DNA (deoxyribonucleic acid) has also been studied. [Pt 2(bipy) 2(DODA/DHDA)](NO 3)2 complexes show high positive cooperative binding to DNA, with Hill coefficients of 1.6 to 1.9, respectively, whereas [Pd 2(bipy) 2(DHDA)](NO 3) gives a biphasic Scatchard plot with two different binding sites or with negative cooperativity.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.